Return to search

SantoSolve Raises $7 Million

SantoSolve AS, an Oslo, Norway-based drug developer focused on pain therapeutics, has raised $7 million in new VC funding. Its lead candidate is for osteoarthritis. DnBNor, Gezina and Glastad Invest were joined on the round by return backers Teknoinvest and InnovationsKapital. www.santosolve.com